NEW YORK (GenomeWeb) – Roche today announced that its cobas HSV 1 and 2 assay has received 510(k) clearance from the US Food and Drug Administration.

The dual target test detects and differentiates herpes simplex virus 1 and 2 DNA in symptomatic patients' anogenital specimens. 

Differentiating HSV-1 from HSV-2 can impact patient management and treatment, but herpes lesions can be confused with other conditions. Molecular testing is faster and is considered more sensitive than traditional viral culture. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.